共 808 条
[1]
Han X(2017)Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy NPJ Precis Oncol 1 31-1770
[2]
Zhou Y(2018)Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it? Eur Heart J 40 1764-731
[3]
Liu W(2015)Systems biology approaches to adverse drug effects: the example of cardio-oncology Nat Rev Clin Oncol 12 718-80
[4]
Stack JP(2017)Cardiovascular toxicities of small molecule tyrosine kinase inhibitors: an opportunity for systems-based approaches Clin Pharmacol Ther 101 65-e602
[5]
Moslehi J(2019)Preventive cardio-oncology: the time has come Front Cardiovasc Med 6 187-774
[6]
Sayed N(2019)Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the American Heart Association Circulation. 139 e579-e66
[7]
Wu JC(2018)Cardiac toxicities in the era of precision medicine: underlying risk factors, targeted therapies, and cardiac biomarkers Am Soc Clin Oncol Educ Book 38 764-734
[8]
Brown SA(2018)Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association Circulation. 137 e30-1467
[9]
Sandhu N(2018)Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger Circulation. 138 727-756
[10]
Herrmann J(2016)Cardiovascular toxic effects of targeted cancer therapies N Engl J Med 375 1457-673